In conclusion, our findings reveal that tumor-derived LCN2 orchestrates a brain-specific metastatic program through dual mechanisms: a paracrine loop involving astrocyte activation and macrophage recruitment and a tumor-intrinsic angiogenic pathway via SLC22A17–JAK2–STAT3–VEGF-A signaling. The gene discussed is LCN2; the disease is neoplasm.